Citron Research says Valeant Pharma (VRX) has better chance than HLF of 'going to $0'

Citron Research says Valeant Pharma (NYSE: VRX) has better chance than HLF of 'going to $0'. Citron said it will have more details on Monday. Calls company 'dirtier' than anyone has reported.

$VRX has a better chance of going to 0 than $HLF EVER will. Citron to update full story on Monday. Dirtier than anyone has reported!!

— Citron Research (@CitronResearch) October 30, 2015

You May Also Be Interested In

• U.S. and Denmark close in on a Greenland deal - Reuters
• Jackson Financial Inc. (JXN) Mentioned as Short at Bear Cave
• Astrana Health (ASTH) Mentioned as short at Glass House